ACADIA Pharmaceuticals Inc.
(NASDAQ:ACAD)|
0.99 -0.20 (-16.81%) Nov 19 - Close |
|
|
|
After-Hours 1.39 +0.40 (40.40%) Wed, 19 Nov 2008 6:50 PM
- Compare ACAD with:
- View: Line | Candlestick
Company Profile
ACADIA Pharmaceuticals Inc.
3911 Sorrento Valley Bould.
San Diego, CA 92121
United States - Map
Phone: (858) 558-2871
Fax: (858) 558-2872
Website: www.acadia-pharm.com
State of incorporation: Delaware
CEO: Dr. Uli Hacksell, Ph.D.
Employees: 143
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Drugs that treat central nervous system disorders
A biopharmaceutical company focusing on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders.
Recent news for ACAD
-
ACADIA PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 11 at 9:04 ET
-
FDA Delays Take Toll on Neuroscience Drug Development
The Wall Street Journal Online - Nov 10 at 4:05 ET
-
ACADIA Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 05 at 10:40 ET
-
ACADIA PHARMACEUTICALS INC Earnings Call scheduled for 5:00 pm ET today
CCBN - Nov 05 at 5:00 ET
-
EDGAR Online - Nov 05 at 4:07 ET
-
ACADIA Pharmaceuticals Reports Third Quarter 2008 Financial Results
Business Wire - Nov 05 at 4:01 ET
-
ACADIA PHARMACEUTICALS INC Earnings Call scheduled for 5:00 pm ET today
CCBN - Nov 05 at 7:35 ET
-
Q3 2008 ACADIA PHARMACEUTICALS INC Earnings Release - After Market Close
CCBN - Nov 05 at 7:07 ET
-
Business Wire - Nov 03 at 9:00 ET
-
ACADIA PHARMACEUTICALS INC Earnings Call scheduled for Wed, Nov 5
CCBN - Oct 29 at 12:10 ET